Heart failure: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• SGLT2 29
• GLP-1 6
• TTR 10
• AMPK 0
• NLRP3 0
• NRF2 0
• PI3K 0
• PPAR 0
• AKT 0
• mTOR 0
• HER2 2
• STAT3 0
• TP53 0
• MAPK 0
• SIRT1 0
• STING 0
• EGFR 0
• GIP 4
• HIF-1 0
• PCSK9 0
• DPP-4 0
• VEGF 0
• HMGB1 0
• IL-6 0
• CTNNB1 0
• TNF 0
• YAP 0
• PINK1 0
• ERK 0
• GPX4 0
• JAK 0
• TLR4 0
• IL-1 0
• JNK 0
• MEK 1
• HSP90 0
• DMD 0
• IL-17 0
• MMP-9 0
• PD-1 0
• CD40 0
• COX-2 0
• HDAC 0
• PD-L1 0
• TFEB 0
• ABL1 0
• APOE 0
• AR 0
• BCL-2 0
• FTO 0
• METTL3 0
• MYC 0
• PTEN 0
• ACE2 0
• BDNF 0
• BRAF 0
• BRD4 0
• BTK 0
• CDK4/6 0
• FAK 0

EU-13 is a filter, not a ranking: it only narrows the list.

17 of 17+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  SGLT2-Inhibitors for Sleep Apnea in Heart Failure

  NCT04640493· Columbia University· Updated 13 May 2024

  “Lack of enrollment”Registry text, quoted unchanged. Source

• Terminated

  SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency

  NCT05737186· Peking University People's Hospital· Updated 30 Apr 2024

  “Double blind packaged drug is up to expiration date”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

  NCT07572032· Kyungsub Song· Source

• Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves

  NCT07610174· Kafrelsheikh University· Source

• Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy

  NCT05890131· Morten Schou· Source

• SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

  NCT05057806· The University of Texas Health Science Center at San Antonio· Source

• Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure

  NCT07478575· University Medical Centre Ljubljana· Source

• Dapagliflozin for Cardio-renal Protection After ICU Discharge

  NCT07025629· Assistance Publique - Hôpitaux de Paris· Source

• Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department

  NCT07392788· Centre Hospitalier Universitaire de Besancon· Source

• Ketones, SGLT2, HFrEF

  NCT06229678· The University of Texas Health Science Center at San Antonio· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 17
• Organoids 5
• Mendelian Randomization Analysis 78
• CRISPR-Cas Systems 7
• Gene Expression Profiling 71
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Exome Sequencing 10
• Proteomics 107
• Metabolomics 64
• Mass Spectrometry 5
• Flow Cytometry 10
• Immunohistochemistry 13
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 37
• Magnetic Resonance Imaging 154
• Machine Learning 195
• Deep Learning 40
• Cohort Studies 495
• Genome-Wide Association Study 74

See which targets of this disease your abstract mentions, and go to the people working on them.